Title : Crystal structure of human acetylcholinesterase in complex with tacrine: Implications for drug discovery.

Pub. Date : 2022 Jun 15

PMID : 35526766






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Being the first marketed drug for AD, tacrine reversibly inhibits AChE and thereby slows the breakdown of the chemical messenger acetylcholine (ACh) in the brain. Tacrine acetylcholinesterase (Cartwright blood group) Homo sapiens
2 However, the atomic level of interactions of tacrine towards human AChE (hAChE) is unknown for years. Tacrine acetylcholinesterase (Cartwright blood group) Homo sapiens
3 However, the atomic level of interactions of tacrine towards human AChE (hAChE) is unknown for years. Tacrine acetylcholinesterase (Cartwright blood group) Homo sapiens
4 Hence, in the current study, we report the X-ray structure of hAChE-tacrine complex at 2.85 A resolution. Tacrine acetylcholinesterase (Cartwright blood group) Homo sapiens
5 The conformational heterogeneity of tacrine within the electron density was addressed with the help of molecular mechanics assisted methods and the low-energy ligand configuration is reported, which provides a mechanistic explanation for the high binding affinity of tacrine towards AChE. Tacrine acetylcholinesterase (Cartwright blood group) Homo sapiens
6 The conformational heterogeneity of tacrine within the electron density was addressed with the help of molecular mechanics assisted methods and the low-energy ligand configuration is reported, which provides a mechanistic explanation for the high binding affinity of tacrine towards AChE. Tacrine acetylcholinesterase (Cartwright blood group) Homo sapiens